GI CONNECT has summarised the highlights of ASCO GI 2017 for you.
Cancers of the upper GI tract by Dr. Thomas Winder
GI CONNECT has summarised the highlights of ASCO GI 2017 for you.
Cancers of the upper GI tract by Dr. Thomas Winder
Dr Thomas Winder is board certified for haematology and medical oncology. Since January 2020 he has been Head of the Department for Haematology and Oncology at the University Teaching Hospital Feldkirch, Austria. In addition, since 2017 he has been President of the Swiss Tumor Molecular Institute in Zürich Switzerland. Dr Winder’s research focuses on molecular markers to individualize medical treatment of cancer patients. He achieved his expertise in internationally renowned laboratories at University of Southern California, Norris Comprehensive Cancer Center, Los Angeles and University Hospital Zürich, Switzerland. His research activity has been honoured by several national and international awards and high impact publications.
Integrating multimodal approaches with multidisciplinary care
Exploring the impact of liquid biopsy in advanced breast cancer
Exploring the impact of molecular subtypes
Expert insights on systemic, loco-regional, and multimodal therapies
Two emerging and two established targets